Twist Bioscience Corp (NASDAQ:TWST) — Market Cap & Net Worth
Market Cap & Net Worth: Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ:TWST) has a market capitalization of $8.26 Billion ($8.26 Billion) as of September 21, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2589 globally and #938 in its home market, demonstrating a 31.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Twist Bioscience Corp's stock price $166.99 by its total outstanding shares 65832424 (65.83 Million). Also see total assets of Twist Bioscience Corp for a full breakdown of the balance sheet.
Twist Bioscience Corp Market Cap History: 2018 to 2026
Twist Bioscience Corp's market capitalization history from 2018 to 2026. Data shows growth from $1.52 Billion to $10.99 Billion (36.93% CAGR). Also see cash efficiency ratio of Twist Bioscience Corp for how efficiently the company converts equity into cash flow.
Index Memberships
Twist Bioscience Corp is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.65 Trillion | 0.31% | #62 of 976 |
|
NASDAQ Composite
IXIC
|
$42.12 Trillion | 0.02% | #302 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.87 Trillion | 0.44% | #43 of 263 |
Weight: Twist Bioscience Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Twist Bioscience Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Twist Bioscience Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check TWST share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
5.55x
Twist Bioscience Corp's market cap is 5.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.52 Billion | $25.43 Million | -$71.24 Million | 59.78x | N/A |
| 2019 | $1.38 Billion | $54.38 Million | -$107.67 Million | 25.42x | N/A |
| 2020 | $9.30 Billion | $90.10 Million | -$139.93 Million | 103.23x | N/A |
| 2021 | $5.09 Billion | $132.33 Million | -$152.10 Million | 38.50x | N/A |
| 2022 | $1.57 Billion | $203.56 Million | -$217.86 Million | 7.70x | N/A |
| 2023 | $2.43 Billion | $245.11 Million | -$204.62 Million | 9.90x | N/A |
| 2024 | $3.06 Billion | $312.97 Million | -$208.73 Million | 9.77x | N/A |
| 2025 | $2.09 Billion | $376.57 Million | -$77.67 Million | 5.55x | N/A |
Competitor Companies of TWST by Market Capitalization
Companies near Twist Bioscience Corp in the global market cap rankings as of September 21, 2026. Review TWST tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Twist Bioscience Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #189 globally with a market cap of $128.84 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #340 globally with a market cap of $79.38 Billion USD.
- CSL Ltd (AU:CSL): Ranked #459 globally with a market cap of $60.28 Billion USD ( AU$85.19 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #189 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $128.84 Billion | $508.34 |
| #340 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.38 Billion | $784.85 |
| #459 | CSL Ltd | AU:CSL | $60.28 Billion | AU$175.59 |
| #505 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $154.04 |
Twist Bioscience Corp Historical Marketcap From 2018 to 2026
Between 2018 and today, Twist Bioscience Corp's market cap moved from $1.52 Billion to $ 10.99 Billion, with a yearly change of 36.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $10.99 Billion | +426.45% |
| 2025 | $2.09 Billion | -31.74% |
| 2024 | $3.06 Billion | +26.07% |
| 2023 | $2.43 Billion | +54.81% |
| 2022 | $1.57 Billion | -69.23% |
| 2021 | $5.09 Billion | -45.23% |
| 2020 | $9.30 Billion | +572.81% |
| 2019 | $1.38 Billion | -9.05% |
| 2018 | $1.52 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 20th, 2026 the market cap of Twist Bioscience Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.26 Billion USD |
| MoneyControl | $8.26 Billion USD |
| MarketWatch | $8.26 Billion USD |
| marketcap.company | $8.26 Billion USD |
| Reuters | $8.26 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo … Read more